Drug Trial Radar · NCT04241315
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
Last checked: Nov 19, 2026Latest source record: Mar 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
112
Actual
Start
Mar 26, 2020
Primary completion
Oct 7, 2021
Study completion Nov 1, 2021
Sponsor
- Lead sponsor
- On Target Laboratories, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Clinipace Worldwide
- First posted
- Jan 27, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/PET/MRI or other imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared Imaging (NIR) at identifying pulmonary nodules within the operating theater, and to assess the safety and tolerability of single intravenous doses of OTL38.
Conditions
- Lung Neoplasms
- Lung Cancer
Interventions
OTL38 for InjectionDrug
Folate analog ligand conjugated with an indole cyanine-like green dye as a solution in vials containing 3 mL at 2 mg/mL
Near infrared camera imaging systemDevice
Near infrared camera imaging system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinically Significant Events (CSE)Time frame: 1 day
- Localization of Primary NoduleTime frame: 1 day
- Identification of Cancerous Synchronous LesionsTime frame: 1 day
- Positive Resection MarginsTime frame: 1 day
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Stamford
Stamford, Connecticut
University of Iowa
Iowa City, Iowa
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Mayo Clinic
Rochester, Minnesota
Cleveland Clinic
Cleveland, Ohio
University of Pennsylvania
Philadelphia, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
MD Anderson Cancer Center
Houston, Texas
University of Virginia
Charlottesville, Virginia
Swedish Hospital
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.